相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Robust HIV-specific CD4+ and CD8+ T-cell responses distinguish elite control in adolescents living with HIV from viremic nonprogressors
Vinicius A. Vieira et al.
AIDS (2022)
Low CCR5 expression protects HIV-specific CD4+T cells of elite controllers from viral entry
Mathieu Claireaux et al.
NATURE COMMUNICATIONS (2022)
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control
Federico Perdomo-Celis et al.
JOURNAL OF CLINICAL INVESTIGATION (2022)
TCF-1 regulates HIV-specific CD8+ T cell expansion capacity
Rachel L. Rutishauser et al.
JCI INSIGHT (2021)
CD8+ T cells fail to limit SIV reactivation following ART withdrawal until after viral amplification
Afam A. Okoye et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Robust and persistent reactivation of SIV and HIV by N-803 and depletion of CD8+ cells
Julia Bergild McBrien et al.
NATURE (2020)
Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection
Louise Leyre et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Rapid viral rebound after analytical treatment interruption in patients with very small HIV reservoir and minimal on-going viral transcription
Pieter Pannus et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2020)
Safety and immunogenicity of Ad26 and MVA vaccines in acutely treated HIV and effect on viral rebound after antiretroviral therapy interruption
Donn J. Colby et al.
NATURE MEDICINE (2020)
NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson et al.
NUCLEIC ACIDS RESEARCH (2020)
TOX is expressed by exhausted and polyfunctional human effector memory CD8+ T cells
Takuya Sekine et al.
SCIENCE IMMUNOLOGY (2020)
Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection
Zaza M. Ndhlovu et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Safety and efficacy of VRC01 broadly neutralising antibodies in adults with acutely treated HIV (RV397): a phase 2, randomised, double-blind, placebo-controlled trial
Trevor A. Crowell et al.
LANCET HIV (2019)
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART
Nadine Bachmann et al.
NATURE COMMUNICATIONS (2019)
Learning From the Exceptions: HIV Remission in Post-treatment Controllers
Behzad Etemad et al.
FRONTIERS IN IMMUNOLOGY (2019)
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector
Lindsey R. Baden et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
Dan H. Barouch et al.
LANCET (2018)
Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection
Donn J. Colby et al.
NATURE MEDICINE (2018)
The Control of HIV after Antiretroviral Medication Pause (CHAMP) study: post-treatment controllers identified from 14 clinical studies
Golnaz Namazi et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
TCF1 expression marks self-renewing human CD8+ T cells
Radomir Kratchmarov et al.
BLOOD ADVANCES (2018)
Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection
Irini Sereti et al.
CLINICAL INFECTIOUS DISEASES (2017)
Origin and differentiation of human memory CD8 T cells after vaccination
Rama S. Akondy et al.
NATURE (2017)
Early antibody therapy can induce long-lasting immunity to SHIV
Yoshiaki Nishimura et al.
NATURE (2017)
Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection
Hiroshi Takata et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation
Dominik Wieland et al.
NATURE COMMUNICATIONS (2017)
CD8+ Lymphocytes Are Required for Maintaining Viral Suppression in SIV-Infected Macaques Treated with Short-Term Antiretroviral Therapy
Emily K. Cartwright et al.
IMMUNITY (2016)
Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand
Merlin L. Robb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Initiation of antiretroviral therapy before detection of colonic infiltration by HIV reduces viral reservoirs, inflammation and immune activation
Trevor A. Crowell et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2016)
Post-Treatment Controllers: Role in HIV Cure Research
Leslie R. Cockerham et al.
CURRENT HIV/AIDS REPORTS (2016)
A low HIV-DNA level in peripheral blood mononuclear cells at antiretroviral treatment interruption predicts a higher probability of maintaining viral control
Lambert Assoumou et al.
AIDS (2015)
Magnitude and Kinetics of CD8+ T Cell Activation during Hyperacute HIV Infection Impact Viral Set Point
Zaza M. Ndhlovu et al.
IMMUNITY (2015)
Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties
Selena Vigano et al.
JOURNAL OF VIROLOGY (2015)
B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers
Yoshinori Fukazawa et al.
NATURE MEDICINE (2015)
Long-lasting stem cell-like memory CD8+ T cells with a naive-like profile upon yellow fever vaccination
Silvia A. Fuertes Marraco et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Immunological biomarkers predict HIV-1 viral rebound after treatment interruption
Jacob Hurst et al.
NATURE COMMUNICATIONS (2015)
Posttreatment controllers: what do they tell us?
Christine Rouzioux et al.
CURRENT OPINION IN HIV AND AIDS (2015)
The CD8+ Memory Stem T Cell (TSCM) Subset Is Associated with Improved Prognosis in Chronic HIV-1 Infection
Susan P. Ribeiro et al.
JOURNAL OF VIROLOGY (2014)
Initiation of ART during Early Acute HIV Infection Preserves Mucosal Th17 Function and Reverses HIV-Related Immune Activation
Alexandra Schuetz et al.
PLOS PATHOGENS (2014)
Immune activation and HIV persistence: implications for curative approaches to HIV infection
Nichole R. Klatt et al.
IMMUNOLOGICAL REVIEWS (2013)
Cutting Edge: Prolonged Exposure to HIV Reinforces a Poised Epigenetic Program for PD-1 Expression in Virus-Specific CD8 T Cells
Ben Youngblood et al.
JOURNAL OF IMMUNOLOGY (2013)
Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size
Vivek Jain et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Transcriptional insights into the CD8+ T cell response to infection and memory T cell formation
J. Adam Best et al.
NATURE IMMUNOLOGY (2013)
A novel acute HIV infection staging system based on 4th generation immunoassay
Jintanat Ananworanich et al.
RETROVIROLOGY (2013)
Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study
Asier Saez-Cirion et al.
PLOS PATHOGENS (2013)
HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy
Cecile Goujard et al.
ANTIVIRAL THERAPY (2012)
Profound metabolic, functional, and cytolytic differences characterize HIV-specific CD8 T cells in primary and chronic HIV infection
Lydie Trautmann et al.
BLOOD (2012)
Ex vivo measurement of the cytotoxic capacity of human primary antigen-specific CD8 T cells
Florentin-Martial Mbitikon-Kobo et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2012)
Clonotype and Repertoire Changes Drive the Functional Improvement of HIV-Specific CD8 T Cell Populations under Conditions of Limited Antigenic Stimulation
Loury Janbazian et al.
JOURNAL OF IMMUNOLOGY (2012)
Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy
B. Shiramizu et al.
JOURNAL OF NEUROVIROLOGY (2012)
Antiretroviral Therapy Reduces the Magnitude and T Cell Receptor Repertoire Diversity of HIV-Specific T Cell Responses without Changing T Cell Clonotype Dominance
Joseph A. Conrad et al.
JOURNAL OF VIROLOGY (2012)
Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2
Morgane Rolland et al.
NATURE (2012)
Immune and Viral Correlates of Secondary Viral Control after Treatment Interruption in Chronically HIV-1 Infected Patients
Ellen Van Gulck et al.
PLOS ONE (2012)
SPICE: Exploration and Analysis of Post-Cytometric Complex Multivariate Datasets
Mario Roederer et al.
CYTOMETRY PART A (2011)
Increased Breadth and Depth of Cytotoxic T Lymphocytes Responses against HIV-1-B Nef by Inclusion of Epitope Variant Sequences
Morgane Rolland et al.
PLOS ONE (2011)
A Novel Immunodominant CD8+T Cell Response Restricted by a Common HLA-C Allele Targets a Conserved Region of Gag HIV-1 Clade CRF01_AE Infected Thais
Supranee Buranapraditkun et al.
PLOS ONE (2011)
Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection
Laurent Hocqueloux et al.
AIDS (2010)
Effector mechanisms in HIV-1 infected elite controllers: Highly active immune responses?
Joel N. Blankson
ANTIVIRAL RESEARCH (2010)
Differentiation and Persistence of Memory CD8+ T Cells Depend on T Cell Factor 1
Xinyuan Zhou et al.
IMMUNITY (2010)
Defective Human Immunodeficiency Virus-Specific CD8+ T-Cell Polyfunctionality, Proliferation, and Cytotoxicity Are Not Restored by Antiretroviral Therapy
Stephen A. Migueles et al.
JOURNAL OF VIROLOGY (2009)
Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells
Luca Gattinoni et al.
NATURE MEDICINE (2009)
Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines
Joseph D. Miller et al.
IMMUNITY (2008)
Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control
Stephen A. Migueles et al.
IMMUNITY (2008)
HLA class I-restricted T-cell responses may contribute to the control of human immunodeficiency virus infection, but such responses are not always necessary for long-term virus control
Brinda Emu et al.
JOURNAL OF VIROLOGY (2008)
Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy
Manuela Rehr et al.
JOURNAL OF VIROLOGY (2008)
Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells
Hendrik Streeck et al.
PLOS MEDICINE (2008)
Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Lydie Trautmann et al.
NATURE MEDICINE (2006)
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Cheryl L. Day et al.
NATURE (2006)
Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection
Hendrik Streeck et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire
D Meyer-Olson et al.
BLOOD (2006)
Antigen-driven effector CD8 T cell function regulated by T-bet
BM Sullivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells
JD Siliciano et al.
NATURE MEDICINE (2003)
HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors
SA Migueles et al.
NATURE IMMUNOLOGY (2002)
HIV-specific CD8+ T cells produce antiviral cytokines but are impaired in cytolytic function
V Appay et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes
A Oxenius et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
